Artemis Alpha | ATS - Ativo Circulante



Ativo Circulante Alterar Data
3i Infrastructure GBP 48M 7M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12